AstraZeneca may consider buying company such as Juno - Bloomberg
June 2 (Reuters) - AstraZeneca Plc (NYSE: AZN - news) would consider buying a company such as Juno Therapeutics Inc (NasdaqGS: JUNO - news) , Bloomberg reported AstraZeneca's CEO as saying, according to StreetInsider.
The companies were not immediately available to comment.
Juno is one among the few companies that are developing a new class of immuno-oncology treatments called CAR (HKSE: 0699.HK - news) -T cell therapies. (Reporting by Amrutha Penumudi in Bengaluru; Editing by Ted Kerr)